OL
Olema
OLMA·NASDAQSan Francisco CAFounded 2006120 employees
Small CapbiotechPublicOncology
Platform: CERAn ER+
Market Cap
$1.5B
All Drugs
2
Clinical Trials
4
Failed / Terminated
1
FDA Approved
0
Stock Price & Catalysts (OLMA)
Loading OLMA stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Motasacituzumab | OLM-4640 | NDA/BLA | 2 | FLT3 | ACC | ||
| Adagraderotide | OLM-3423 | Phase 2 | 2 | EGFR | Bladder CaCF |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (4)